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Abstract
Measles virus (MV) efficiently causes generalized immunosuppression which accounts to a 
major extent for cases of measles-asscociated severe morbidity and mortality. MV infections 
alter many functions of antigen presenting cells (APC) (dendritic cells (DCs)) and lymphocytes, 
yet many molecular targets of the virus remain poorly defined. Cellular interactions and effector 
functions of DCs and lymphocytes are regulated by surface receptors. Associating with other 
proteins involved in cell signaling, receptors form part of receptosomes that respond to and 
transmit external signals through dynamic interctions with the cytoskeleton. Alterations in the 
composition and metabolism of membrane sphingolipids have a substantial impact on both 
processes. In this review we focus on the regulation of sphingomyelinase activity and ceramide 
release in cells exposed to MV and discuss the immunosuppressive role of sphingomyelin 
breakdown induced by MV. 
Introduction
As established more than a century ago, MV efficiently suppresses especially the 
adaptive immune response and this almost entirely accounts for the high rates of morbidity/
mortality associated with acute measles [1]. Typically, patients succumb to secondary infections, which may follow a fatal course, and chronic or latent infections may exacerbate 
due to the loss of mainly T cell dependent immune control. Quantitative and qualitative 
alterations of peripheral blood lymphocytes typically occur during or for weeks after the 
acute infection. These include lymphopenia, an early switch from a Th1 towards a Th2 
dominated response and a general inability of peripheral blood lymphocytes  to expand 
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in response to polyclonal or antigen-specific stimulation ex vivo [1, 2]. The latter two 
characteristics mark MV as a pathogen specifically targeting cellular immunity for efficient 
generalised immunosuppression. 
Interaction with its plasma membrane surface receptors is of major importance for 
measles pathogenesis also including immunosuppression [3, 4]. Though all of them are 
signaling active molecules, only three receptors confer viral uptake into target cells: CD46 (used by attenuated strains in vitro [5]), nectin-4 (expressed on the basolateral side of 
epithelial cells, and important for viral shedding from infected hosts [6, 7]), and CD150 (also refered to as SLAMF1 [8]). In vivo, MV uptake and hematopoietic spread clearly segregate 
with CD150 expression patterns [9, 10]. While MV interaction with pattern recognition 
receptors such as DC-SIGN and TLR2 was linked to enhancement of viral uptake into or 
maturation of APCs [11, 12], respectively, that with others such as FcgRII or an as yet 
undefined receptor (see below) was implicated in modulating lymphocyte viability and 
activity in immunosuppression [13, 14]. Within the following paragraphs we will highlight 
the role of stimulated sphingomyelin breakdown at the plasma membrane in two important 
aspects of MV induced immunomodulation: DC entry and T cell silencing. 
MV-DC interactions: sphingolipid breakdown mediated enhancement of infection
The importance of the MV entry receptor, CD150, for major aspects of MV pathogenesis 
received direct support from studies performed in experimentally infected rhesus macaques. 
CD150 expression is confined to hematopoetic cells, and predominantly activated follicular B 
and memory T lymphocytes are infected in secondary lymphatic tissues and, at low frequency, 
in PBMCs [10, 15]. Lending support to the hypothesis that APCs in the lower respiratory 
tract are early, if not prime target cells for viral infection, MV infected CD150+ alveolar 
macrophages and CD11c+ MHC class-II+ myeloid DCs were detected in peripheral tissues 
early following infection [10, 16]. This suggests that MV initially interacts with immature 
DCs and exploits them as Trojan horses for transport into T cell rich areas in secondary 
lymphatic tissues where transmission to lymphocytes occurs [13, 14, 17, 18]. Unlike HIV, for 
which a similar scenario is postulated, MV efficiently infects DCs and this occurs in a CD150-
dependent manner enhanced by DC-SIGN [12, 19]. DC-SIGN, in conjunction with TLR2, 
may also promote phenotypic and functional DC maturation [11, 12] which resembles that 
induced by other viruses in terms of MHC- and costimulatory molecule upregulation and 
cytokine release, though CCR7 upregulation and CD40 signaling may be compromised [20, 
21]. To what extent these virus-induced alterations translate into the inability of MV-infected 
DCs to stimulate T cell proliferation is unknown [13, 14]. There is, however, evidence that 
the majority of conjugates formed between T cells and infected DCs is unstable and does not 
sustain Ca2+-mobilization in T cells [22]. It appears that in addition to inadequate expression 
and recruitment of repulsion receptors and their ligands inhibitory signals provided by the 
viral glycoprotein on the DC surface to conjugating T cells are essentially involved in this 
process [23, 24], thereby rendering MV uptake for subsequent replication highly important 
in DC-mediated T cell silencing. 
Surface expression of the MV uptake receptor CD150 is low on myeloid DCs in vitro and 
in vivo [19, 25], and membrane compartimentalization or clustering of this receptor has not 
yet been addressed on these cells. Lateral segregation followed by receptor concentration 
also including those for pathogens was, however, described following acid sphingomyelinase 
(ASM) activation, subsequent ceramide release and condensation of ceramide microdomains 
into extended ceramide enriched platforms [26, 27]. DC-SIGN is the major MV attachment 
receptor on DCs [19, 28]. Its signaling involves activation of c-Raf which, in general, can 
be subject to ceramide mediated regulation [29, 30], and therefore, DC-SIGN appeared to 
be a likely candidate in promoting sphingomyelinase activation leading to MV receptor 
clustering. Indeed, DC-SIGN ligation by MV, but also specific antibodies after crosslink 
or mannan efficiently caused transient ASM activation and surface display of ASM and 
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ceramides, and this was sensitive to EGTA, amitriptyline and DC-SIGN blocking antibodies 
[25]. Pharmacological or siRNA-mediated genetic ablation of ASM did not affect MV binding 
to DCs, however, severely impaired uptake as detected by accumulation of viral proteins 
after 16 hrs. This was not observed in cell lines where the uptake receptor was abundantly 
expressed corroborating our hypothesis that DC-SIGN mediated ASM activation regulated 
entry receptor availability. While lateral co-segregation of abundantly expressed CD150 and 
transgenic DC-SIGN was observed after mannan exposure in Raji B cells, DC-SIGN ligation 
caused a transient increase in CD150 surface display within minutes in DCs indicating that 
in these cells, ASM activation caused vertical rather than lateral CD150 recruitment [25]. It 
appeared that CD150 was co-transported with ASM from a common intracellular storage 
compartment. 
There are several implications of this study that extend beyond the MV system: DC-SIGN 
ligation is not unique to MV. Receptor sorting upon DC-SIGN mediated ASM activation and 
formation of ceramide-enriched platforms on DCs might well positively, but also negatively 
regulate pathogen uptake. Thus, sphingomyelinase exposure caused segregation CD4 from 
CXCR4 and thus inhibition of fusion-mediated HIV-1 uptake, and rather fostered viral 
endocytosis followed by lysosomal targeting [31]. Whether this would also occur in response 
to ASM activation has not been tested, nor has it been assessed in viral systems whether ASM 
activity supports membrane fusion as revealed for phago-lysosomal fusion in macrophages infected with L. monocytogenes [32, 33]. Thus, while consequences of DC-SIGN dependent 
ASM activation in pathogen uptake are not MV-specific, CD150 recruitment seemingly is. 
Because CD150 can, however, serve as pathogen recognition receptor routing gram-negative 
bacteria into an endolysosomal degradative compartment in murine macrophages [34], 
transient availability of this receptor could be important in co-infection settings. Apart from 
enhancing MV uptake, ASM activation was also found to be required for DC-SIGN proximal 
and downstream signaling [25]. While a role of ASM in membrane proximal c-Raf and ERK 
activation was not surprising, inhibition of NF-kB upon TLR4 co-ligation was unexpected, 
because enhancement of LPS-driven NF-kB activation upon DC-SIGN co-ligation was 
described to occur in DCs earlier [30]. While reasons for these discrepant observations 
have not been unraveled as yet, ASM activation in response to DC-SIGN ligation appears to 
regulate gene expression in DCs especially with regard to cytokine release, which, again, 
would be DC-SIGN, but not MV-specific. 
MV-interaction with T cells: actin cytoskeletal paralysis and beyond
Several scenarios relating to MV T cell interference were described. These include 1) 
loss of viability occuring due to infection and/or infection-independent apoptosis. The latter can be caused by ligation of the FcgRII [35], while infection related loss may result from viral 
cytolysis, formation of multinucleated giant cells or destruction by virus-specific effector T 
cells in secondary lymphatic tissues [15]. Because this has been particularly revealed for 
the memory T cell population, both lymphopenia but also loss of recall responses during 
measles were attributed to this mechanism [15]. 2) A general cytokine imbalance was described in vitro and in vivo in that an initial Th1 rapidly shifts towards a Th2 response 
thereby disfavoring cellular immunity [1]. 3) Thirdly, expansion of T cells isolated from 
patients in response to polyclonal or antigen-specific activation is strongly impaired. The 
latter phenomenon has been mimicked by exposure of primary or transformed T cells to the 
MV glycoprotein complex provided by infected cells, cells transfected to express this effector 
complex or viral particles. T cell inhibition in this system does not involve infection or cell 
death, but rather a profound inability to pass beyond the G1 phase [3].
It was for several reasons that regulation of phospholipid dynamics was likely of 
importance in MV T cell silencing. Binding of purified MV causes condensation of detergent resistant membrane microdomains on resting T cells and abolishes signaling initiated from 
the IL-2R and TCR at a membrane proximal level in vitro and ex vivo [36, 37]. MV targets 
activation of the PI3K, and consequently, generation of membrane phosphatidyl-inositol-
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3,4,5-phosphate (PIP
3
) and recruitment of PH domain containing proteins (including Akt 
kinase and the guanosin exchange factor Vav) [37]. Akt inhibition is crucial to MV T cell 
silencing, because this is efficiently abrogated upon expression of a constitutively membrane 
associated, active Akt kinase [36]. As they are PI3K downstream effectors, MV impaired 
nuclear accumulation of certain splice accessory factors thereby giving rise to production of 
protein isoforms translated from alternatively spliced mRNAs. These included a constitutively 
membrane associated active lipid phosphatase (SIP110) which on overexpression interfered 
with T cell expansion, most likely by constitutively depleting PIP
3
 at the cell membrane [38]. 
As a second major target of MV T cell silencing, integrity and dynamics of cortical actin 
proved to be effectively disturbed (refered to as T cell paralysis) which is characterized by 
a failure to 1) adhere to and morphologically polarise on fibronectin (FN), 2) to recruit Vav 
and activate small GTPases Rac1 and Cdc42 and 3) to phosphorylate ezrin/moesin proteins 
and cofilin, which when dephosphorylated, severs barbed ends of actin filaments, upon TCR 
ligation [39]. Phenotypically, MV exposure causes a rapid collapse of actin based protrusions 
in T cells which, on stimulation, are unable to spread, form lamellopodia, and correctly 
organize monocentric immune synapses (ISs) with mature DCs [39]. Moreover, ISs formed 
between infected DCs and T cells were mostly unstable and did not support sustained 
Ca2+-fluxing thereby explaining why infected DCs do not promote T cell expansion [22, 24, 
40]. Because both membrane phospholipid metabolism and actin dynamics are essential 
components of IS function [41, 42], it is not surprising that a virus interfering at these levels 
is highly efficient at abrogating T cell activation. 
Several lines of evidence suggested that sphingomyelinase activation and ceramide 
release might contribute to MV-mediated T cell silencing mainly including their interference 
with Akt activation, cytoskeletal remodeling and ERM protein activity (though not revealed 
in T cells) [43-46] as well as their ability to hamper TCR-stimulated CRAC channel activation 
and subsequent Ca2+-influx [47, 48]. Moreover, inhibition of T cell proliferation was reported 
after NSM activation upon choleratoxin binding to lipid rafts or exogenous elevation of 
ceramides [49, 50].
Indeed, MV causes surface accumulation of ceramides due to activation of both NSM 
and ASM (the latter being displayed at the surface), with NSM most likely accounting 
for ASM activation. This was related to the MV gp interaction since a recombinant MV, 
expressing VSV G protein instead (MGV) failed to activate sphingomyelinases [3, 51]. MV-
induced sphingomyelinase activation appeared not to account for loss of stimulated T cell 
proliferation, but rather for that of membrane protrusions and efficiently interfered with 
FN- or aCD3/CD28-stimulated T cell polarisation, surface receptor redistribution, ezrin/
moesin phosphorylation, and directional cell motility. Bacterial sphingomyelinase or 
biologically active C16-ceramide caused similar effects when applied instead of MV, and thus, 
our observations apparently reflect a general, as yet unnoted ceramide dependent block in 
T cell cytoskeletal dynamics and thereby, activation [51]. Interestingly, ASM deficient T cells 
revealed an aberrant morphology as well in that they developed prominent ruffles instead of 
microvillar structures and were unable to polarise their cortical actin on fibronectin (Avota 
and Schneider-Schaulies, unpublished). These observations indicate that temporally and 
spatially controlled sphingomyelinase activation may be of crucial importance in cytoskeletal dynamics in T cells thereby controlling essential functions such as adherence, migration, and 
interaction with APCs. 
Outlook
Formation of unstable ISs with MV-infected DCs which do not support sustained Ca2+ mobilization in T cells strongly suggests that MV targets their architecture and function for T cell silencing. Because formation of functional ISs is critical to T cell activation, not 
surprisingly pathogens other than MV also target this interaction for intervention. This has 
been documented for DCs infected with respiratory syncytial virus or ISs involving HIV-
infected T cells [52-55]. 
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How sphingomyelin breakdown/ceramide release might regulate of IS function and 
what would be the targets is certainly a highly interesting subject to address. Little is known 
about the role of sphingomyelinase activity in DC maturation and function as yet nor has it 
been directly assessed whether association of surface receptors important in DC function 
(such as for instance CD80, CD86 or CD40) with microdomains is subject to regulation in 
response to sphingomyelinase activation. If, as revealed for other cell types, MV gps would be 
located in lipid rafts in DCs as well, they might redistribute upon sphingomyelin breakdown 
thereby possibly affecting interaction with receptors on T cells required for transmission of 
activatory signals. Much less studied as for T cells, actin remodeling and protrusion of actin 
based extensions are also critical for the ability of DCs to promote T cell activation [56], and 
it would be interesting to see whether this would be positively of negatively affected upon 
sphingomyelinase activation. As evident from several studied, sphingomyelinase activation/
ceramide release interferes with T cell activation, for instance by affecting actin cytoskeletal 
remodeling and sustained Ca2+ mobilization [47, 48, 51], however, targets remain as yet 
obscure. In line with their inhibitory function, ceramide species are virtually absent from the 
lipid environment of activated TCR clusters [57]. It will thus be highly interesting to directly 
reveal as to whether infectious agents (or compounds thereof) interfering with IS function 
would cause either of these effects, and if so, define microdomains targeted within the IS. 
This, however, will only become feasible once the experimental tools will become available to address this issue. 
Acknowledgement
We thank Erich Gulbins, Essen for excellent cooperation and the Deutsche 
Forschungsgemeinschaft for funding our laboratory work relating to the subject of this 
review (SPP1267). 
Disclosure Statement
We disclose any sponsorship relating to our research and conflicts of interest.
References 
1 Griffin DE: Measles virus-induced suppression of immune responses. Immunol Rev 2010;236:176-189.
2 Schneider-Schaulies S, Schneider-Schaulies J: Measles virus-induced immunosuppression. Curr Top 
Microbiol Immunol 2009;330:243-269.
3 Avota E, Gassert E, Schneider-Schaulies S: Measles virus-induced immunosuppression: from effectors to 
mechanisms. Med Microbiol Immunol 2010;199:227-237.
4 Schneider-Schaulies J, Schneider-Schaulies S: Receptor interactions, tropism, and mechanisms involved in 
morbillivirus-induced immunomodulation. Adv Virus Res 2008;71:173-205.
5 Yanagi Y, Takeda M, Ohno S, Hashiguchi T: Measles virus receptors. Curr Top Microbiol Immunol 
2009;329:13-30.
6 Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD: Tumor Cell Marker PVRL4 (Nectin 
4) Is an Epithelial Cell Receptor for Measles Virus. PLoS Pathog 2011;7:e1002240.
7 Muhlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VH, Navaratnarajah CK, Frenzke M, Wong 
XX, Sawatsky B, Ramachandran S, McCray PB Jr, Cichutek K, von Messling V, Lopez M, Cattaneo R: Adherens 
junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011;480:530-533.
8 Tatsuo H, Ono N, Tanaka K, Yanagi Y: SLAM (CDw150) is a cellular receptor for measles virus. Nature 
2000;406:893-897.
9 de Swart RL: The pathogenesis of measles revisited. Pediatr Infect Dis J 2008;27:S84-88.
10 de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, Yuksel S, Geijtenbeek TB, 
Duprex WP, Osterhaus AD: Predominant infection of CD150+ lymphocytes and dendritic cells during 
measles virus infection of macaques. PLoS Pathog 2007;3:e178.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Physiol Biochem 2014;34:20-26
DOI: 10.1159/000362981
Published online: June 16, 2014
© 2014 S. Karger AG, Basel
www.karger.com/cpb 25
Avota/Schneider-Schaulies: Measles Virus in Sphingomyelinase Activation
Cellular Physiology 
and Biochemistry
11 Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter 
Meulen V, Schneider-Schaulies S: Hemagglutinin protein of wild-type measles virus activates toll-like 
receptor 2 signaling. J Virol 2002;76:8729-8736.
12 de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB: Measles virus targets DC-SIGN to 
enhance dendritic cell infection. J Virol 2006;80:3477-3486.
13 Kerdiles YM, Sellin CI, Druelle J, Horvat B: Immunosuppression caused by measles virus: role of viral 
proteins. Rev Med Virol 2006;16:49-63.
14 Schneider-Schaulies S, Dittmer U: Silencing T cells or T-cell silencing: concepts in virus-induced 
immunosuppression. J Gen Virol 2006;87:1423-1438.
15 de Vries RD, McQuaid S, van Amerongen G, Yuksel S, Verburgh RJ, Osterhaus AD, Duprex WP, de Swart RL: 
Measles immune suppression: lessons from the macaque model. PLoS Pathog 2012;8:e1002885.
16 Lemon K, de Vries RD, Mesman AW, McQuaid S, van Amerongen G, Yuksel S, Ludlow M, Rennick LJ, Kuiken 
T, Rima BK, Geijtenbeek TB, Osterhaus AD, Duprex WP, de Swart RL: Early target cells of measles virus after 
aerosol infection of non-human primates. PLoS Pathog 2011;7:e1001263.
17 Pohl C, Shishkova J, Schneider-Schaulies S: Viruses and dendritic cells: enemy mine. Cell Microbiol 
2007;9:279-289.
18 Schneider-Schaulies S, Klagge IM, ter Meulen V: Dendritic cells and measles virus infection. Curr Top 
Microbiol Immunol 2003;276:77-101.
19 de Witte L, de Vries RD, van der Vlist M, Yuksel S, Litjens M, de Swart RL, Geijtenbeek TB: DC-SIGN and 
CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS 
Pathog 2008;4:e1000049.
20 Servet-Delprat C, Vidalain PO, Bausinger H, Manie S, Le Deist F, Azocar O, Hanau D, Fischer A, Rabourdin-
Combe C: Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J 
Immunol 2000;164:1753-1760.
21 Abt M, Gassert E, Schneider-Schaulies S: Measles virus modulates chemokine release and chemotactic 
responses of dendritic cells. J Gen Virol 2009;90:909-914.
22 Shishkova Y, Harms H, Krohne G, Avota E, Schneider-Schaulies S: Immune synapses formed with measles 
virus-infected dendritic cells are unstable and fail to sustain T cell activation. Cell Microbiol 2007;9:1974-
1986.
23 Tran-Van H, Avota E, Bortlein C, Mueller N, Schneider-Schaulies S: Measles virus modulates dendritic 
cell/T-cell communication at the level of plexinA1/neuropilin-1 recruitment and activity. Eur J Immunol 
2011;41:151-163.
24 Klagge IM, ter Meulen V, Schneider-Schaulies S: Measles virus-induced promotion of dendritic cell 
maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins 
on the cell surface. Eur J Immunol 2000;30:2741-2750.
25 Avota E, Gulbins E, Schneider-Schaulies S: DC-SIGN mediated sphingomyelinase-activation and ceramide 
generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog 2011;7:e1001290.
26 Gulbins E, Dreschers S, Wilker B, Grassme H: Ceramide, membrane rafts and infections. J Mol Med 
2004;82:357-363.
27 Gulbins E, Kolesnick R: Raft ceramide in molecular medicine. Oncogene 2003;22:7070-7077.
28 Koethe S, Avota E, Schneider-Schaulies S: Measles virus transmission from dendritic cells to T cells: 
formation of synapse-like interfaces concentrating viral and cellular components. J Virol 2012;86:9773-
9781.
29 Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R: Phosphorylation of Raf by ceramide-activated 
protein kinase. Nature 1995;378:307-310.
30 Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB: C-type lectin DC-SIGN 
modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-
kappaB. Immunity 2007;26:605-616.
31 Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH Jr, Blumenthal R: Sphingomyelinase 
restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J Virol 
2007;81:5294-5304.
32 Utermohlen O, Herz J, Schramm M, Kronke M: Fusogenicity of membranes: the impact of acid 
sphingomyelinase on innate immune responses. Immunobiology 2008;213:307-314.
33 Utermohlen O, Karow U, Lohler J, Kronke M: Severe impairment in early host defense against Listeria 
monocytogenes in mice deficient in acid sphingomyelinase. J Immunol 2003;170:2621-2628.
34 Berger SB, Romero X, Ma C, Wang G, Faubion WA, Liao G, Compeer E, Keszei M, Rameh L, Wang N, Boes 
M, Regueiro JR, Reinecker HC, Terhorst C: SLAM is a microbial sensor that regulates bacterial phagosome 
functions in macrophages. Nat Immunol 2010;11:920-927.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell Physiol Biochem 2014;34:20-26
DOI: 10.1159/000362981
Published online: June 16, 2014
© 2014 S. Karger AG, Basel
www.karger.com/cpb 26
Avota/Schneider-Schaulies: Measles Virus in Sphingomyelinase Activation
Cellular Physiology 
and Biochemistry
35 Laine D, Bourhis JM, Longhi S, Flacher M, Cassard L, Canard B, Sautes-Fridman C, Rabourdin-Combe C, 
Valentin H: Measles virus nucleoprotein induces cell-proliferation arrest and apoptosis through NTAIL-NR 
and NCORE-FcgammaRIIB1 interactions, respectively. J Gen Virol 2005;86:1771-1784.
36 Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, ter Meulen V, Schneider-Schaulies S: Disruption of Akt 
kinase activation is important for immunosuppression induced by measles virus. Nat Med 2001;7:725-731.
37 Avota E, Muller N, Klett M, Schneider-Schaulies S: Measles virus interacts with and alters signal 
transduction in T-cell lipid rafts. J Virol 2004;78:9552-9559.
38 Avota E, Harms H, Schneider-Schaulies S: Measles virus induces expression of SIP110, a constitutively 
membrane clustered lipid phosphatase, which inhibits T cell proliferation. Cell Microbiol 2006;8:1826-
1839.
39 Muller N, Avota E, Schneider-Schaulies J, Harms H, Krohne G, Schneider-Schaulies S: Measles virus contact 
with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering. 
Traffic 2006;7:849-858.
40 Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S: Induction 
of maturation of human blood dendritic cell precursors by measles virus is associated with 
immunosuppression. Proc Natl Acad Sci USA 1997;94:5326-5331.
41 Billadeau DD, Burkhardt JK: Regulation of cytoskeletal dynamics at the immune synapse: new stars join the 
actin troupe. Traffic 2006;7:1451-1460.
42 Gombos I, Kiss E, Detre C, Laszlo G, Matko J: Cholesterol and sphingolipids as lipid organizers of the 
immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes 
and T-cell death. Immunol Lett 2006;104:59-69.
43 Bourbon NA, Sandirasegarane L, Kester M: Ceramide-induced inhibition of Akt is mediated through protein 
kinase Czeta: implications for growth arrest. J Biol Chem 2002;277:3286-3292.
44 Zeidan YH, Jenkins RW, Hannun YA: Remodeling of cellular cytoskeleton by the acid sphingomyelinase/
ceramide pathway. J Cell Biol 2008;181:335-350.
45 Hannun YA, Obeid LM: Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell 
Biol 2008;9:139-150.
46 Canals D, Roddy P, Hannun YA: Protein phosphatase 1alpha mediates ceramide-induced ERM protein 
dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and 
myosin/ERM phosphatase. J Biol Chem 2012;287:10145-10155.
47 Lepple-Wienhues A, Belka C, Laun T, Jekle A, Walter B, Wieland U, Welz M, Heil L, Kun J, Busch G, Weller M, 
Bamberg M, Gulbins E, Lang F: Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through 
sphingomyelinase and sphingolipids. Proc Natl Acad Sci USA 1999;96:13795-13800.
48 Church LD, Hessler G, Goodall JE, Rider DA, Workman CJ, Vignali DA, Bacon PA, Gulbins E, Young SP: TNFR1-
induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx. J 
Leukoc Biol 2005;78:266-278.
49 Rouquette-Jazdanian AK, Foussat A, Lamy L, Pelassy C, Lagadec P, Breittmayer JP, Aussel C: Cholera 
toxin B-subunit prevents activation and proliferation of human CD4+ T cells by activation of a neutral 
sphingomyelinase in lipid rafts. J Immunol 2005;175:5637-5648.
50 O'Byrne D, Sansom D: Lack of costimulation by both sphingomyelinase and C2 ceramide in resting human 
T cells. Immunology 2000;100:225-230.
51 Gassert E, Avota E, Harms H, Krohne G, Gulbins E, Schneider-Schaulies S: Induction of membrane 
ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral 
immunosuppression. PLoS Pathog 2009;5:e1000623.
52 Gonzalez PA, Prado CE, Leiva ED, Carreno LJ, Bueno SM, Riedel CA, Kalergis AM: Respiratory syncytial 
virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci USA 
2008;105:14999-15004.
53 Fackler OT, Alcover A, Schwartz O: Modulation of the immunological synapse: a key to HIV-1 pathogenesis? 
Nat Rev Immunol 2007;7:310-317.
54 Haller C, Rauch S, Fackler OT: HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular 
localization and TCR induced actin remodeling. PLoS ONE 2007;2:e1212.
55 Millington OR, Gibson VB, Rush CM, Zinselmeyer BH, Phillips RS, Garside P, Brewer JM: Malaria impairs 
T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog 
2007;3:1380-1387.
56 Benvenuti F, Hugues S, Walmsley M, Ruf S, Fetler L, Popoff M, Tybulewicz VL, Amigorena S: Requirement of 
Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 2004;305:1150-1153.
57 Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, Harder T: Accumulation of raft lipids in T-cell 
plasma membrane domains engaged in TCR signalling. Embo J 2009;28:466-476.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
